Sonodynamic effects of lomefloxacin derivatives conjugated with methoxy polyethylene glycol on sarcoma 180 cells

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 243-248

  Komori, Chiyo ^a   Okada, Kyoji ^b   Kawamura, Koichi ^b   Suzuki, Norio ^a,b   Chida, Shuichi ^b   Suzuki, Toshio ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lomefloxacin; Polyethylene glycol; Sarcoma180; Sonodynamic

Indexed keywords

HISTIDINE; LOMEFLOXACIN; LOW MOLECULAR WEIGHT PEGYLATED LOMEFLOXACIN; MACROGOL; MANNITOL; METHOXYPOLYETHYLENE GLYCOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADD ON THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SONODYNAMIC THERAPY; SURVIVAL RATE; ULTRASOUND THERAPY;

ANIMALS; DRUG SYNERGISM; FLUOROQUINOLONES; HISTIDINE; MALE; MANNITOL; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; OXYGEN; POLYETHYLENE GLYCOLS; SARCOMA 180; SUPEROXIDE DISMUTASE; ULTRASONIC THERAPY;

EID: 61449208125     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Umemura S, Yumita N and Nishigaki R: Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex. Jpn J cancer Res 84: 582-588, 1993.
2. Tachibana K, Uchida T, Tamura K, Eguchi H, Yamashita N and Ogawa K: Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett 149: 189-194, 2000.
3. Yumita N, Kawabata K, Sasaki K and Umemura S: Sonodynamic effect of erythrosine B on sarcoma 180 cells in vitro. Ultrason Sonochem 9: 259-265, 2002.
4. Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11: 349-363, 2004.
5. Yumita N, Nishigaki R, Umemura K and Umemura S: Synergistic effect of ultrasound and hematoporphyrin on sarcoma 180. Jpn J Caner Res 81: 304-308, 1990.
6. Yumita N, Sasaki K, Umemura S and Nishigaki R: Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 87: 310-316, 1996.
7. Sakusabe N, Okada K, Sato K, Kamada S, Yoshida Y and Suzuki T: Enhanced sonodynamic antitumor effect of ultrasound in the presence of nonsteroidal anti-inflammatory drugs. Jpn J Cancer Res 90: 1146-1151, 1999.
8. Yumita N, Nishigaki R, Sakata I, Nakajima S and Umemura S: Sonodynamically induced antitumor effect of 4-formyl-oximethylidene-3- hydroxy-2-vinyl-deuterio-porphynyl (IX)-6,7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91: 255-260, 2000.
9. Yu T, Wang Z and Mason TJ: A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11: 95-103, 2004.
10. Liu Q, Wang X, Wang P and Xiao L: Sonodynamic antitumor effect of protoporphyrin IX disodium salt on S180 solid tumor. Chemotherapy 53: 429-436, 2007.
11. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 80: 219-222, 1989.
12. Umemura S, Yumita N, Nishigaki R and Umemura K: Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81: 962-966, 1990.
13. Milowska K and Gabryelak T: Synergistic effect of ultrasound and phthalocyanines on nucleated erythrocytes in vitro. Ultrasound Med Biol 31: 1707-1712, 2005.
14. Liu Q, Wang X, Wang P, Qi H, Zhang K and Xiao L: Sonodynamic effects of protoporphyrin IX disodium sait on isolated sarcoma 180 cells. Ultrasonics 45: 56-60, 2006.
15. Hachimine K, Shibaguchi H, Kuroki M, Yamada H, Kinugasa T, Nakae Y, Asano R, Sakata I, Yamashita Y, Shirakusa T and Kuroki M: Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity. Cancer Sci 98: 916-920, 2007.
16. Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, Yanagisawa J, Kinugasa T, Tanaka T and Yamashita Y: Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res 27: 3673-3677, 2007.
17. Huang D, Okada K, Komori C, Itoi E, Kawamura K and Suzuki T: Ultrastructure of sarcoma 180 cells after ultrasound irradiation in the presence of sparfloxacin. Anticancer Res 24: 1553-1559, 2004.
18. Huang D, Okada K, Komori C, Itoi E and Suzuki T: Enhanced antitumor activity of ultrasonic irradiation in the presence of new quinolone antibiotics in vitro. Cancer Sci 95: 845-849, 2004.
19. Abuchowski A, Van Es T, Palczuk NC and Davis FF: Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252: 3578-3581, 1977.
20. Abuchowski A, Kazo GM, Verhoest CR Jr, Van Es T, Kafkewitz D, Nucci ML, Viau AT and Davis FF: Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem Biophys 7: 175-186, 1984.
21. Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T and Maeda H: Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 89: 307-314, 1998.
22. Greenwald RB: PEG drugs: an overview. J Control Release 74: 159-171, 2001.
23. Greenwald RB, Choe YH, McGuire J and Conover CD: Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 55: 217-250, 2003.
24. Suzuki N, Okada K, Chida S, Komori C, Shimada Y and Suzuki T: Antitumor effect of acridine orange under ultrasonic irradiation in vitro. Anticancer Res 27: 4179-4184, 2007.
25. Suslick KS: Sonochemistry. Science 247: 1439-1445, 1990.
26. Yumita N, Nishigaki R, Umemura K, Morse PD, Swartz HM, Cain CA and Umemura S: Sonochemical activation of hematoporphyrin: an ESR study. Radiat Res 138: 171-176, 1994.
27. Sugita N, Kawabata K, Sasaki K, Sakata I and Umemura S: Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation. Bioconjug Chem 18: 866-873, 2007.
28. Tabata Y, Murakami Y and Ikada Y: Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J Cancer Res 88: 1108-1116, 1997.